Erinn Myers, MD
Urogynecology and Reconstructive Pelvic Surgery · Charlotte, NCNPI 1255545448
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.8%), education and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 83.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $11,402 and has fallen 98.0% since, to $227 in 2025. Among urogynecology and reconstructive pelvic surgery clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 64 payments — averaging $463.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$25K
- Boston Scientific$1K
- Conmed Corporation$1K
- Teleflex Medical Incorporated$600
- Coopersurgical, Inc.$494
- Baxter Healthcare$416
- plus $690 from 6 others
What the payments were for
- Consulting fees$1,6005%
- Speaking & faculty fees$14,77550%
- Travel & lodging$2,5919%
- Food & beverage$4,65916%
- Education$6,00020%
- Gifts$280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 40 | $24,800 |
| Boston Scientific | 3 | $1,450 |
| Conmed Corporation | 3 | $1,202 |
| Teleflex Medical Incorporated | 1 | $600 |
| Coopersurgical, Inc. | 5 | $494 |
| Baxter Healthcare | 3 | $416 |
| Coloplast | 3 | $291 |
| Abbott | 1 | $185 |
| Caldera Medical, Inc | 1 | $105 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $61 |
| TELA Bio, Inc. | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$19,236
- DA VINCI SP$4,900
- Advantage System$1,275
- VCARE$1,145
- Percutaneous Solutions: PERCUVANCE & MiniLap brands$600
- TISSEEL$416
- Uterine Manipulators & Injectors$212
- PROCLAIM$185
- RESTORELLE$165
- Advincula Delineator Uterine Manipulator$146
- AIRSEAL$145
- Desara$105
- UPSYLON$101
How this compares
$29,653 in reported general payments places this provider in the 90th percentile of 35 urogynecology and reconstructive pelvic surgery providers in North Carolina.
See all urogynecology and reconstructive pelvic surgery providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 17 | $12,415 |
| GemtesaVibegron | 14 | $9,133 |
| Estradiol | 43 | $2,937 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $16 | $9,13314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 35 urogynecology and reconstructive pelvic surgery providers in North Carolina.
Other urogynecology and reconstructive pelvic surgery in Charlotte
- Cary FishburneCharlotte$231K
- William PorterCharlotte$157K
- Kevin SteppCharlotte$10K
- Catherine MatthewsWinston Salem$70K
- Nazema SiddiquiDurham$29K
- Amie KawasakiDurham$27K
- Cindy AmundsenDurham$19K
- Rahul DuttaWinston Salem$13K
- Sarah BradleyCary$11K
- Christine ChuChapel Hill$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.